📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials (2017)

First Author: Olsson B

Attributed to: UK Dementias Platform funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/14737175.2017.1341311

PubMed Identifier: 28604243

Publication URI: http://europepmc.org/abstract/MED/28604243

Type: Journal Article/Review

Parent Publication: Expert Review of Neurotherapeutics

Issue: 8

ISSN: 1473-7175